Clinical trials
Completed Candidiasis, Invasive trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 1 |
| 2007 | 5 |
| 2008 | 1 |
| 2009 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2020 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 18 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pfizer | 4 |
| Astellas Pharma Inc | 3 |
| Scynexis, Inc. | 3 |
| Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2 |
| Duke University | 2 |
| CanXida | 1 |
| Kevin Watt | 1 |
| Mundipharma Research Limited | 1 |
| Mycoses Study Group | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Candidiasis, Invasive | 18 |
| Candidemia | 13 |
| Candidiasis | 8 |
| Mycoses | 5 |
| Fungemia | 3 |
| Invasive Fungal Infections | 2 |
| Pathologic Processes | 2 |
| Sepsis | 2 |
| Systemic Inflammatory Response Syndrome | 2 |
| Aspergillosis, Allergic Bronchopulmonary | 1 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.